Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene

Marianne R. Spalinger(University of Zurich), Declan F. McCole(University of California, Riverside)
Cellular and Molecular Gastroenterology and Hepatology
January 1, 2025
Cited by 3


Related Papers